MedPath

To compare & evaluate guava leaf powder in the treatment of periodontal osseous defects

Phase 2
Conditions
Health Condition 1: K053- Chronic periodontitis
Registration Number
CTRI/2023/08/056500
Lead Sponsor
il
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients with stage III periodontitis assessed by probing pocket depth (PPD) >= 6mm, interdental clinical attachment loss (CAL) >= 5mm.

2) Patients with two or three wall intraosseous defects in either maxillary or mandibular arch or interarch.

Exclusion Criteria

1) Patients with history of systemic diseases, allergies or drug usage.

2) Patients who have undergone periodontal treatment in previous 6 months.

3) Pregnant or lactating women.

4) Smokers, tobacco chewers and patients with poor oral hygiene index (PI >1.5) will be excluded from the study.

5) In addition, tooth with caries, mobility > grade II will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Probing pocket depth(PPD), Clinical Attachment Level <br/ ><br>(CAL)Timepoint: baseline 3 & 6 months
Secondary Outcome Measures
NameTimeMethod
Plaque Index (PI), Gingival Index (GI)Timepoint: baseline 3 & 6 months
© Copyright 2025. All Rights Reserved by MedPath